# Acknowledgements

This work was supported by NIH DP5-OD019815 to A.S.M., a Terri Brodeur Breast Cancer Foundation Fellowship to A.S.M., DFG-CRC1181-A07 to F.N., DFG-TRR130-P13 to F.N., and in part by the UCLA Jonsson Comprehensive Cancer Center (JCCC) grant NIH P30-CA016042. The authors wish to thank Song Yi Bae, Simin Manole, and Ted Richards for helpful feedback. **Competing financial interests:** The authors declare no competing financial interests.

# Author contributions statement

A.S.M. and F.N. conceived the experiment(s),  A.S.M., R.A.R., M.B., N.G., and A.L. conducted the experiments and analyzed the results.  All authors reviewed the manuscript.

| **Antigen** | **Isotype** | **Clone** | **Provider** |
| ----------- | ----------- | --------- | ------------ |
| **CD11b**   | rat IgG2b   | M1/70     | AbD Serotec; BioLegend |
| **CD45**    | rat IgG2b   | 30-F11    | BD Biosciences, BioLegend |
| **CD62L**   | rat IgG2a   | MEL-14    | eBioscience, BioLegend |
| **Gr-1 (Ly6G/C)** | rat IgG2b | RB6-8C5 | BD Biosciences, BioLegend |
| **Ly6G**    | rat IgG2a   | 1A8       | BD Biosciences, BioLegend |
| **NK1.1**   | mouse IgG2a | PK136     | Southern Biotech; Biolegend |
| **FcγR1 (CD64)** | mouse IgG1 | X54-5/7.1 | BD Biosciences |
| **FcγR2b (CD32b)** | mouse IgG2a | Ly17.2 | In-house |
| **FcγR3 (CD16)** | rat IgG2a | 275003 | R&amp;D Systems Europe |
| **FcγR4**   | Arm. hamster | 9E9      | In-house; Biolegend |

Table S2. **Antibodies for cell identification and mFcγR quantitation.**